Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
NCT00729599
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Hygiene
Interventions
DRUG:
Cetylpyridinium chloride
Sponsor
Sanofi